Dergiler / Records of Natural Products / 2019 / Cilt: 13 - Sayı: 6

Protein Tyrosine Phosphatase 1B Inhibitors from the Root Bark of Pseudolarix amabilis (Nelson) Rehd. (Pinaceae)

Sayfa
475–482
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, their pharmacological inhibitory bioactivities on PTP1B enzyme were evaluated, and the three oleanane-type compounds 1-3 exhibited inhibitory bioactivities with IC50 values of 1.90 ± 0.37, 19.15 ± 0.10 and 10.44 ± 0.59 μM, respectively.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pseudolarix amabilis (Nelson) Rehd, is a monotypic genus plant belonging to the family Pinaceae.
📊
Temel Bulgular & Veri:During our activity screening, the water-soluble part of the 70% EtOH extract of P. amabilis bark showed excellent inhibitory bioactivities on PTP1B enzyme, leading to the phytochemical isolation of the root bark of P. amabilis.
💡
Sonuç & Katkı:In addition, their pharmacological inhibitory bioactivities on PTP1B enzyme were evaluated, and the three oleanane-type compounds 1-3 exhibited inhibitory bioactivities with IC50 values of 1.90 ± 0.37, 19.15 ± 0.10 and 10.44 ± 0.59 μM, respectively.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Pseudolarix amabilis (Nelson) Rehd, is a monotypic genus plant belonging to the family Pinaceae. The root bark , known as “Tu-Jin-Pi” has been used for the treatment of skin diseases. During our activity screening, the water-soluble part of the 70% EtOH extract of P. amabilis bark showed excellent inhibitory bioactivities on PTP1B enzyme, leading to the phytochemical isolation of the root bark of P. amabilis. Three oleanane-type compounds (1-3) and seven phenolic compounds (4-10) were isolated, in which oleanolic acid 3- O-β-D-glucuronyl-6′-ethyl ester (1) was identified as a new saponin. The chemical structures of these compounds were elucidated by 1D/2D nuclear magnetic resonance and high resolution mass spectra. In addition, their pharmacological inhibitory bioactivities on PTP1B enzyme were evaluated, and the three oleanane-type compounds 1-3 exhibited inhibitory bioactivities with IC50 values of 1.90 ± 0.37, 19.15 ± 0.10 and 10.44 ± 0.59 μM, respectively.

🔖

Bu Makaleye Atıf Yap

YUE, Z., ZHOU, R., HE, Y., XU, H., PAN, Y., LEI, L., XIE, P., TANG, Z., DUAN, J. (2019). Protein Tyrosine Phosphatase 1B Inhibitors from the Root Bark of Pseudolarix amabilis (Nelson) Rehd. (Pinaceae). Records of Natural Products, Cilt: 13 - Sayı: 6, 475–482. https://ajindex.com/articles/308631

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Z. Zhang, G. Dodd and T. Tiganis (2015). Protein tyrosine phosphatases in hypothalamic insulin and leptin signaling, Trends. Pharmacol. Sci. 36, 661-674
  2. J. Bakke and F. Haj (2015). Protein-tyrosine phosphatase 1B substrates and metabolic regulation, Semin. Cell. Dev. Biol. 37, 58-65
  3. E. Panzhinskiy, J. Ren and S. Nair (2013). Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus, Curr. Med. Chem. 20, 2609-2625
  4. S. Zhang and Z. Zhang (2007). PTP1B as a drug target: recent developments in PTP1B inhibitor discovery, Drug. Discov. Today 12, 373-381
  5. I. Lund, J. Hansen, H. Andersen, N. Moller and N. Billestrup (2005). Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signaling, J. Mol. Endocrinol. 34, 339-351
  6. R. He, Z. Yu, R. Zhang and Z. Zhang (2014). Protein tyrosine phosphatases as potential therapeutic targets, Acta. Pharmacol. Sin. 35, 1227-1246
  7. S. Yip, S. Saha and J. Chernoff (2010). PTP1B: a double agent in metabolism and oncogenesis, Trends. Biochem. Sci. 35, 442-449
  8. N. Tonks and S. Muthuswamy (2007). A brake becomes an accelerator: PTP1B-a new therapeutic target for breast cancer, Cancer Cell 11, 214-216
  9. S. Wu, R. Hu and G. Yang (1960). Experimental, clinical and pharmacological study on the antifungal effects of Pesudolarix kaempferi Gord., Chin. J. Dermatol. 8, 18-25
  10. P. Chiu, L. Leung and B. Ko (2010). Pseudolaric acids: isolation, bioactivity and synthetic studies, Nat. Prod. Rep. 27, 1066-1083
  11. G. Chen, Z. Li, D. Pan, C. Tang, X. He, G. Xu, K. Chen and K. Lee (1993). The isolation and structural elucidation of four novel triterpene lactones, pseudolarolides A, B, C, and D, from Pseudolarix kaempferi, J. Nat. Prod. 56, 1114-1122
  12. P. Liu, H. Guo, W. Wang, J. Zhang, N. Li, J. Han, J. Zhou, Y. Hu, T. Zhang, Z. Liu and D. Guo (2007). Cytotoxic diterpenoids from the bark of Pseudolarix kaempferi and their structure-activity relationships, J. Nat. Prod. 70, 533-537
  13. S. Yang, Y. Cai, B. Zhang, L. Tong, H. Xie, Y. Wu, L. Lin, J. Ding and J. Yue (2008). Structural modification of an angiogenesis inhibitor discovered from traditional Chinese medicine and a structureactivity relationship study, J. Med. Chem. 51, 77-85
  14. Y. Tong, X. Zhang, M. Geng, J. Yue, X. Xin, F. Tian, X. Shen, L. Tong, M. Li, C. Zhang, W. Li, L. Lin, J. Ding (2006). Pseudolarix acid B, a new tubulin-binding agent,